158 related articles for article (PubMed ID: 11186133)
1. Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity.
Pirmohamed M; Alfirevic A; Vilar J; Stalford A; Wilkins EG; Sim E; Park BK
Pharmacogenetics; 2000 Nov; 10(8):705-13. PubMed ID: 11186133
[TBL] [Abstract][Full Text] [Related]
2. Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.
Kagaya H; Miura M; Niioka T; Saito M; Numakura K; Habuchi T; Satoh S
Antimicrob Agents Chemother; 2012 Feb; 56(2):825-9. PubMed ID: 22106207
[TBL] [Abstract][Full Text] [Related]
3. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
4. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
5. The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation.
Gill HJ; Tjia JF; Kitteringham NR; Pirmohamed M; Back DJ; Park BK
Pharmacogenetics; 1999 Feb; 9(1):43-53. PubMed ID: 10208642
[TBL] [Abstract][Full Text] [Related]
6. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
[TBL] [Abstract][Full Text] [Related]
9. Influence of CYP2C9, GSTM1, GSTT1 and NAT2 genetic polymorphisms on DNA damage in workers occupationally exposed to organophosphate pesticides.
Singh S; Kumar V; Singh P; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Rai A
Mutat Res; 2012 Jan; 741(1-2):101-8. PubMed ID: 22108250
[TBL] [Abstract][Full Text] [Related]
10. Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity.
Alfirevic A; Stalford AC; Vilar FJ; Wilkins EG; Park BK; Pirmohamed M
Br J Clin Pharmacol; 2003 Feb; 55(2):158-65. PubMed ID: 12580987
[TBL] [Abstract][Full Text] [Related]
11. Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.
O'Neil WM; MacArthur RD; Farrough MJ; Doll MA; Fretland AJ; Hein DW; Crane LR; Svensson CK
J Clin Pharmacol; 2002 Jun; 42(6):613-9. PubMed ID: 12043950
[TBL] [Abstract][Full Text] [Related]
12. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
13. Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients.
Carr A; Gross AS; Hoskins JM; Penny R; Cooper DA
AIDS; 1994 Mar; 8(3):333-7. PubMed ID: 8031511
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China.
Chen HC; Cao YF; Hu WX; Liu XF; Liu QX; Zhang J; Liu J
Dis Markers; 2006; 22(3):141-52. PubMed ID: 16788248
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study.
Rodrigo L; Alvarez V; Rodriguez M; Pérez R; Alvarez R; Coto E
Scand J Gastroenterol; 1999 Mar; 34(3):303-7. PubMed ID: 10232877
[TBL] [Abstract][Full Text] [Related]
16. Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants.
Zielińska E; Niewiarowski W; Bodalski J; Rebowski G; Skretkowicz J; Mianowska K; Sekulska M
Pharm World Sci; 1998 Jun; 20(3):123-30. PubMed ID: 9618736
[TBL] [Abstract][Full Text] [Related]
17. Genotype and allele frequencies of isoniazid-metabolizing enzymes NAT2 and GSTM1 in Latvian tuberculosis patients.
Igumnova V; Capligina V; Krams A; Cirule A; Elferts D; Pole I; Jansone I; Bandere D; Ranka R
J Infect Chemother; 2016 Jul; 22(7):472-7. PubMed ID: 27236516
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
19. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
[TBL] [Abstract][Full Text] [Related]
20. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]